| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 4, 2025 | Dec 8, 2025 | Surrozen, Inc./DE | Director | Buy | 85.0 | +36,150 | 1.67% | ✗ | $694.9K |
| Nov 13, 2025 | Dec 2, 2025 | Surrozen, Inc./DE | Director | Buy | 100.0 | +315,457 | 17.10% | ✗ | $4M |
| Apr 4, 2024 | Apr 17, 2024 | Surrozen, Inc./DE | Director | Buy | 100.0 | +193,548 | 45.76% | ✗ | $3M |
| Apr 4, 2024 | Apr 8, 2024 | Surrozen, Inc./DE | Director | Buy | 100.0 | +193,548 | 44.59% | ✗ | $3M |
| May 25, 2022 | May 27, 2022 | RAPT Therapeutics, Inc. | 10% Owner | Buy | 56.3 | +1,900 | 0.07% | ✗ | $23.7K |
| May 23, 2022 | May 25, 2022 | RAPT Therapeutics, Inc. | 10% Owner | Buy | 75.0 | +26,550 | 0.68% | ✗ | $323.7K |
| May 10, 2022 | May 12, 2022 | RAPT Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +1,250,000 | 39.72% | ✗ | $13.3M |
| Sep 27, 2021 | Sep 29, 2021 | RAPT Therapeutics, Inc. | 10% Owner | Sell | 30.0 | -9,239 | -0.65% | ✗ | $319.4K |
| Sep 14, 2021 | Sep 16, 2021 | RAPT Therapeutics, Inc. | 10% Owner | Sell | 16.3 | -181,211 | -9.66% | ✗ | $6.7M |
| Sep 10, 2021 | Sep 14, 2021 | RAPT Therapeutics, Inc. | 10% Owner | Sell | 17.5 | -985,383 | -30.21% | ✗ | $1.3M |
| Sep 1, 2021 | Sep 3, 2021 | RAPT Therapeutics, Inc. | 10% Owner | Sell | 17.5 | -68,850 | -2.52% | ✗ | $2.4M |
| Aug 20, 2021 | Aug 24, 2021 | RAPT Therapeutics, Inc. | 10% Owner | Sell | 17.5 | -95,746 | -2.90% | ✗ | $3M |
| Nov 16, 2020 | Nov 18, 2020 | Revolution Medicines, Inc. | 10% Owner | Sell | 15.0 | -2,027,156 | -30.68% | ✗ | $73.8M |
| Sep 22, 2020 | Sep 23, 2020 | RAPT Therapeutics, Inc. | 10% Owner | Sell | 15.0 | -608,000 | -13.68% | ✗ | $18.8M |
| Aug 17, 2020 | Aug 19, 2020 | RAPT Therapeutics, Inc. | 10% Owner | Sell | 15.0 | -538,654 | -10.81% | ✗ | $12.3M |
| Nov 4, 2019 | Nov 4, 2019 | RAPT Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +625,000 | 14.34% | ✗ | $7.5M |